GO:0048261 negative regulation of receptor-mediated endocytosis: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048261 describes any process that stops, prevents, or reduces the frequency, rate, or extent of receptor-mediated endocytosis, the receptor-dependent uptake of external materials by cells.
• Negative regulation of receptor-mediated endocytosis is essential for controlling nutrient uptake, signaling strength, and cellular homeostasis, and its dysregulation is linked to aging, metabolic disease, and impaired blood-brain transport [1,2].
• Key molecular players include receptor phosphorylation, PKCδ, ORAI channels, Spns1, and megalin, which together tune endocytic flux [3,4,6,8].
• Aging and senescence are associated with reduced receptor-mediated endocytosis, and restoring this process can reverse functional decline in senescent cells [2,7].
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable precise dissection of negative regulators of receptor-mediated endocytosis [4,6,8].
• Studying GO:0048261 requires combining imaging, proteomics, and functional uptake assays to resolve where and how endocytosis is inhibited [1,6].
Description
Receptor-mediated endocytosis is a fundamental cellular process by which cells internalize specific extracellular molecules through surface receptors. GO:0048261, negative regulation of receptor-mediated endocytosis, refers to any process that stops, prevents, or reduces the frequency, rate, or extent of this uptake mechanism. This regulatory term is critical because uncontrolled endocytosis can lead to excessive nutrient accumulation, aberrant signaling, or pathological transport, while insufficient endocytosis contributes to aging-related hyporesponsiveness and impaired clearance of metabolites [1,2]. Researchers study GO:0048261 to understand how cells balance uptake and retention of ligands such as cholesterol, albumin, and iron carriers, and to identify therapeutic targets for diseases ranging from neurodegeneration to metabolic disorders [4,5,6]. The process is tightly controlled by phosphorylation events, ion channels, and intracellular trafficking proteins, making it a rich area for CRISPR-based functional genomics [3,6,8].
negative regulation of receptor-mediated endocytosis At A Glance
| GO ID | GO:0048261 |
|---|---|
| GO term | negative regulation of receptor-mediated endocytosis |
| Ontology | biological_process |
| Synonym | down regulation of receptor mediated endocytosis; down-regulation of receptor mediated endocytosis; downregulation of receptor mediated endocytosis; inhibition of receptor mediated endocytosis; negative regulation of receptor mediated endocytosis |
| Major function | Reduces the frequency, rate, or extent of receptor-mediated endocytosis, thereby limiting uptake of external materials and modulating downstream signaling. |
| Biological context | Implicated in aging, senescence, metabolic transport, and immune cell phagocytosis [1,2,7,8]. |
| Key regulators | Receptor phosphorylation, PKCδ, ORAI channels, Spns1, and megalin-dependent pathways [3,4,6,8]. |
| Research relevance | Target for restoring endocytic function in senescence and for controlling nutrient uptake in disease [2,7]. |
What Is GO:0048261?
According to the Gene Ontology, GO:0048261 (negative regulation of receptor-mediated endocytosis) is defined as any process that stops, prevents, or reduces the frequency, rate or extent of receptor mediated endocytosis, the uptake of external materials by cells, utilizing receptors to ensure specificity of transport. In simpler terms, it is the cellular brake that slows down or blocks the receptor-driven import of molecules from the outside environment.
Why Is negative regulation of receptor-mediated endocytosis Important in Cell Biology?
Negative regulation of receptor-mediated endocytosis is important because it acts as a rheostat for cellular uptake, preventing excessive accumulation of ligands such as cholesterol and albumin while preserving signaling fidelity [5,6]. Dysregulation of this process is linked to age-related decline in blood-brain transport, senescence-associated hyporesponsiveness, and impaired immune phagocytosis, making it a focal point for understanding tissue aging and metabolic disease [1,2,8].
• Controls the rate of nutrient and ligand uptake, including cholesterol and albumin [5,6].
• Prevents overstimulation of signaling pathways by limiting receptor internalization.
• Contributes to age-related impairment of blood-brain transport.
• Is responsible for senescence-associated hyporesponsiveness, which can be reversed by restoring endocytosis [2,7].
• Modulates Fcγ receptor-mediated phagocytosis in macrophages through PKCδ.
• Involves ion channels such as ORAI that are critical for albumin endocytosis.
• Requires iron transporter Spns1 for megalin-dependent endocytosis.
• Provides a therapeutic target for metabolic and neurodegenerative conditions [1,4].
• Can be studied with CRISPR screens to identify novel negative regulators [4,6,8].
• Helps explain how cells adapt to changing extracellular environments [2,7].
What Happens During negative regulation of receptor-mediated endocytosis?
Receptor phosphorylation and signaling shutdown
In simple terms: Adding phosphate groups to receptors can turn off their ability to bring molecules into the cell.
Phosphorylation of transmembrane receptors is a key mechanism that regulates signaling and can lead to reduced receptor-mediated endocytosis. This modification often triggers conformational changes or recruitment of inhibitory proteins that decrease the rate of uptake.
Ion channel and transporter control
In simple terms: Channels and transporters can act as gatekeepers that slow down endocytosis.
ORAI channels are critical for receptor-mediated endocytosis of albumin, and their activity can modulate the efficiency of this process. Similarly, Spns1, an iron transporter, is essential for megalin-dependent endocytosis, linking metal homeostasis to endocytic regulation.
Kinase and phosphatase modulation
In simple terms: Enzymes that add or remove phosphate groups can put the brakes on endocytosis.
Protein kinase Cδ negatively regulates class IA phosphoinositide 3-kinase, which in turn limits Fcγ receptor-mediated phagocytosis in macrophages. This demonstrates how kinase signaling cascades can suppress endocytic events.
Senescence and aging-associated decline
In simple terms: As cells age, they often become less able to take in molecules, partly because endocytosis is down-regulated.
Down-regulation of receptor-mediated endocytosis is responsible for senescence-associated hyporesponsiveness, and restoration of this process can lead to functional recovery of senescent cells [2,7]. Physiological blood-brain transport is also impaired with age due to a shift in transcytosis, highlighting the importance of negative regulation in aging.
Cholesterol and lipid transport feedback
In simple terms: When cells have enough cholesterol, they can slow down the uptake of cholesterol-carrying particles.
Transport of cholesterol involves receptor-mediated uptake, and negative regulation of this endocytosis helps maintain lipid homeostasis. This feedback prevents excessive cholesterol accumulation and is critical for cellular health.
Key Genes Involved in GO:0048261 negative regulation of receptor-mediated endocytosis
The following genes and proteins have been experimentally linked to the negative regulation of receptor-mediated endocytosis, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PKCδ | Negatively regulates class IA PI3K, limiting Fcγ receptor-mediated phagocytosis | Target for modulating immune cell uptake |
| ORAI | Calcium channel critical for receptor-mediated endocytosis of albumin | Potential regulator of albumin uptake in kidney and other tissues |
| Spns1 | Iron transporter essential for megalin-dependent endocytosis | Links iron metabolism to endocytic regulation |
| Megalin | Multiligand receptor whose endocytosis can be negatively regulated | Model for studying receptor trafficking |
| Fcγ receptor | Mediates phagocytosis that is negatively regulated by PKCδ | Immune function and macrophage biology |
| LDL receptor | Mediates cholesterol uptake that is subject to negative regulation | Cardiovascular and metabolic research |
| Albumin receptor | Mediates albumin endocytosis regulated by ORAI channels | Kidney and vascular biology |
| PI3K class IA | Lipid kinase inhibited by PKCδ, affecting endocytosis | Signaling node in endocytic control |
| Transferrin receptor | Classic receptor for iron uptake, subject to regulation | Iron homeostasis studies |
| Insulin receptor | Receptor tyrosine kinase whose internalization is regulated | Diabetes and metabolism research |
| β2-adrenergic receptor | G protein-coupled receptor regulated by phosphorylation | Cardiovascular signaling |
| Clathrin | Structural component of endocytic vesicles | Core endocytic machinery |
| Dynamin | GTPase required for vesicle scission | Endocytosis inhibitor target |
| Caveolin | Component of caveolae-mediated endocytosis | Transcytosis and transport studies |
| Rab5 | Early endosome marker and regulator | Trafficking research |
| Rab7 | Late endosome regulator | Endosomal maturation |
| LAMP1 | Lysosomal marker linked to endocytic degradation | Lysosomal function |
How Is negative regulation of receptor-mediated endocytosis Regulated?
Negative regulation of receptor-mediated endocytosis is itself regulated by phosphorylation events, kinase cascades such as PKCδ, and ion channel activity [3,6,8]. Additionally, aging and senescence can shift the balance toward reduced endocytosis, and restoring endocytic capacity can reverse some senescent phenotypes [2,7]. Cholesterol transport feedback also modulates the rate of receptor-mediated uptake to maintain lipid homeostasis.
negative regulation of receptor-mediated endocytosis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PKCδ | Immune dysfunction, phagocytosis defects | Knockout macrophages |
| ORAI | Kidney albuminuria, vascular disease | Point-mutation knock-in mice |
| Spns1 | Iron overload, megalin-dependent endocytosis defects | Knockout renal cells |
| LDL receptor | Hypercholesterolemia | Overexpression hepatocytes |
| Megalin | Proteinuria, neurodegeneration | Knock-in tagged receptor |
Aging and Neurodegeneration
Physiological blood-brain transport is impaired with age due to a shift in transcytosis, which involves changes in receptor-mediated endocytosis. This decline may contribute to neurodegeneration by limiting nutrient and clearance functions.
Metabolic Disorders
Negative regulation of receptor-mediated endocytosis affects cholesterol uptake, and dysregulation can lead to lipid accumulation or deficiency. Albumin endocytosis regulated by ORAI channels is also relevant to kidney and vascular function.
Immune Dysfunction
PKCδ-mediated negative regulation of Fcγ receptor phagocytosis in macrophages is critical for immune balance, and its perturbation may contribute to inflammatory diseases.
Senescence and Age-Related Diseases
Senescence-associated hyporesponsiveness is caused by down-regulation of receptor-mediated endocytosis, and restoration of this process can improve cellular function [2,7].
From negative regulation of receptor-mediated endocytosis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PKCδ increase Fcγ receptor-mediated phagocytosis? | PKCδ knockout macrophages |
| Does ORAI channel mutation affect albumin endocytosis? | ORAI point-mutation knock-in cells |
| Can restoring endocytosis reverse senescence? | Overexpression of endocytic regulators in senescent cells |
| What is the role of Spns1 in megalin-dependent endocytosis? | Spns1 knockout renal epithelial cells |
| How does aging affect blood-brain transport? | Aged mouse models with tagged receptors |
| Does cholesterol feedback regulate LDL receptor endocytosis? | LDL receptor knock-in reporter cells |
How to Study the negative regulation of receptor-mediated endocytosis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescent ligand uptake | Rate of receptor-mediated endocytosis | Live-cell imaging |
| Phosphoproteomics | Phosphorylation of receptors and signaling proteins | Identify regulatory modifications |
| CRISPR knockout screen | Genes that negatively regulate endocytosis | Discovery of novel regulators |
| RNA-seq | Transcriptional changes in endocytic genes | Senescence and aging studies |
| Proximity ligation assay | Protein-protein interactions in endocytic pathway | Validate regulatory complexes |
| Live-cell microscopy | Vesicle trafficking and receptor internalization | Real-time endocytosis dynamics |
| Western blot | Protein levels of endocytic markers | Validation of knockout or overexpression |
| Flow cytometry | Cell surface receptor levels | Quantify internalization |
Imaging-based uptake assays
Fluorescently labeled ligands such as transferrin or albumin can be used to measure endocytic rate in live cells, revealing negative regulation.
Proteomics and phosphoproteomics
Mass spectrometry can identify phosphorylation changes on receptors and signaling proteins that mediate negative regulation.
CRISPR screening
Genome-wide knockout screens can uncover novel negative regulators of receptor-mediated endocytosis [4,8].
Transcriptomics and RNA-seq
RNA sequencing can reveal changes in gene expression associated with senescence and endocytic decline [2,7].
How CRISPR Can Be Used to Study GO:0048261 negative regulation of receptor-mediated endocytosis
Knockout
CRISPR knockout of candidate negative regulators such as PKCδ or Spns1 can confirm their role in suppressing receptor-mediated endocytosis [4,8].
Point Mutation
Introducing point mutations in receptors or channels like ORAI can dissect specific phosphorylation or ion transport sites required for negative regulation.
Knock-in
Knock-in of tagged receptors (e.g., GFP-tagged megalin) allows real-time tracking of endocytosis and its regulation.
Overexpression
Overexpression of negative regulators can reduce endocytic uptake, providing gain-of-function evidence for their inhibitory role.
How EDITGENE Supports negative regulation of receptor-mediated endocytosis Research
Researchers studying negative regulation of receptor-mediated endocytosis-related genes often need to determine whether a candidate gene is causally involved in suppressing uptake, and CRISPR-based models provide the most direct way to test this.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of receptor-mediated endocytosis research.
Frequently Asked Questions About negative regulation of receptor-mediated endocytosis
What is negative regulation of receptor-mediated endocytosis?
It is any process that stops, prevents, or reduces the frequency, rate, or extent of receptor-mediated endocytosis, the receptor-dependent uptake of external materials.
What genes are involved in negative regulation of receptor-mediated endocytosis?
Key genes include PKCδ, ORAI, Spns1, megalin, and Fcγ receptor, among others [4,6,8].
How does aging affect receptor-mediated endocytosis?
Aging is associated with down-regulation of receptor-mediated endocytosis, leading to senescence-associated hyporesponsiveness and impaired blood-brain transport [1,2].
What is the role of PKCδ in endocytosis?
PKCδ negatively regulates class IA PI3K, which limits Fcγ receptor-mediated phagocytosis in macrophages.
How do ORAI channels regulate endocytosis?
ORAI channels are critical for receptor-mediated endocytosis of albumin, and their activity modulates uptake efficiency.
What is Spns1 and how does it relate to endocytosis?
Spns1 is an iron transporter essential for megalin-dependent endocytosis, linking iron homeostasis to endocytic regulation.
Can CRISPR be used to study negative regulation of receptor-mediated endocytosis?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect this process [4,6,8].
What diseases are linked to defective negative regulation of receptor-mediated endocytosis?
Aging-related neurodegeneration, metabolic disorders, immune dysfunction, and senescence-associated diseases [1,2,5,8].
How is cholesterol transport related to this GO term?
Cholesterol uptake via receptor-mediated endocytosis is subject to negative regulation to maintain lipid homeostasis.
What methods are used to study negative regulation of receptor-mediated endocytosis?
Fluorescent ligand uptake, phosphoproteomics, CRISPR screens, RNA-seq, and live-cell imaging are commonly used [1,3,4,6].
Conclusion
GO:0048261, negative regulation of receptor-mediated endocytosis, is a critical biological process that controls how cells limit the uptake of external molecules. Its dysregulation contributes to aging, metabolic disease, and immune dysfunction, making it a key area for therapeutic intervention [1,2,8]. By leveraging CRISPR-based models and advanced omics, researchers can uncover new regulators and translate these findings into clinical applications [4,6,7].
References
- 1. Yang AC et al.. 2020. Physiological blood-brain transport is impaired with age by a shift in transcytosis.. Nature 583(7816):425-430 PMID: 32612231
- 2. Park SC et al.. 2002. Down-regulation of receptor-mediated endocytosis is responsible for senescence-associated hyporesponsiveness.. Ann N Y Acad Sci 959:45-9 PMID: 11976184
- 3. Sibley DR et al.. 1987. Regulation of transmembrane signaling by receptor phosphorylation.. Cell 48(6):913-22 PMID: 3030559
- 4. Beenken A et al.. 2024. Spns1 is an iron transporter essential for megalin-dependent endocytosis.. Am J Physiol Renal Physiol 327(5):F775-F787 PMID: 39265081
- 5. Norum KR et al.. 1983. Transport of cholesterol.. Physiol Rev 63(4):1343-419 PMID: 6361811
- 6. Zeng B et al.. 2017. ORAI channels are critical for receptor-mediated endocytosis of albumin.. Nat Commun 8(1):1920 PMID: 29203863
- 7. Park SC. 2002. Functional recovery of senescent cells through restoration of receptor-mediated endocytosis.. Mech Ageing Dev 123(8):917-26 PMID: 12044940
- 8. Hazeki K et al.. 2009. Negative regulation of class IA phosphoinositide 3-kinase by protein kinase Cdelta Limits Fcgamma receptor-mediated phagocytosis in macrophages.. J Biochem 145(1):87-94 PMID: 18974158
